Sign in

You're signed outSign in or to get full access.

Joanne Medero

About Joanne T. Medero

Independent trustee of Nuveen Mortgage & Income Fund (JLS) since 2021; Class III Board Member with term expiring at the 2027 annual meeting. Year of birth 1954. Former Managing Director at BlackRock and Barclays with deep public policy, legal, and derivatives regulation expertise; J.D. from George Washington University Law School and B.A. from St. Lawrence University. The Nuveen funds classify her as an Independent Board Member (not an “interested person”) under the 1940 Act.

Past Roles

OrganizationRoleTenureCommittees/Impact
BlackRock, Inc.Managing Director, Government Relations & Public Policy; Senior Advisor to Vice Chairman2009–2020; 2018–2020Corporate governance and public policy focus
Barclays Group (IBIM)Managing Director, Global Head of Government Relations & Public Policy2006–2009Led legislative/regulatory advocacy for IB/IM/WM businesses
Barclays Global InvestorsManaging Director; Global General Counsel & Corporate Secretary1996–2006Global legal leadership for asset manager
Orrick, Herrington & Sutcliffe LLPPartner1993–1995Derivatives and financial markets regulation
Commodity Futures Trading CommissionGeneral Counsel1989–1993Top legal officer; U.S. derivatives oversight
The White House, Office of Presidential PersonnelDeputy Associate Director/Associate Director (Legal & Financial Affairs)1986–1989Senior policy staffing

External Roles

OrganizationRoleTenureNotes
Baltic-American Freedom FoundationDirectorSince 2019Non-profit board service
SIFMA Asset Management GroupSteering Committee Chair2016–2018Industry leadership
Managed Funds AssociationChair, CTA/CPO & Futures Committee2010–2012Industry policy role
The Federalist Society (Corporations, Antitrust & Securities Practice Group)Chair2010–2022 and 2000–2002Policy/legal community leadership

Board Governance

  • Independence: All current trustees and nominees, including Medero, are “Independent Board Members” (not interested persons of the Funds or the Adviser/TIAA/Nuveen).
  • Committee memberships (JLS board complex):
    • Compliance, Risk Management & Regulatory Oversight Committee (member)
    • Nominating & Governance Committee (member)
    • Investment Committee (member)
    • Not a member of the Audit, Dividend, Executive, or Closed-End Fund Committees.
  • Attendance: Each Board Member attended at least 75% of Board and committee meetings in the last fiscal year.
  • Board class/tenure: Class III trustee; current term runs to 2027 for funds where applicable; she joined the Nuveen funds boards in 2021.
  • JLS 2024 meeting load (last fiscal year):
    • Regular Board: 5; Special Board: 9; Executive: 5; Dividend: 10; Compliance: 5; Audit: 14; Nominating & Governance: 5; Investment: 4; Closed-End Fund: 4.

Fixed Compensation

  • Structure (Independent Trustees; effective dates apply complex-wide and are allocated across funds):
    • Through Dec 31, 2023: $210,000 annual retainer; per-meeting fees (e.g., $7,250 regular Board, $4,000 special Board, $2,500 Audit/Closed-End/Investment, $5,000 Compliance, etc.); chair retainers up to $140,000; site visit fees and ad hoc fees as described.
    • Effective Jan 1, 2024: $350,000 annual retainer; committee membership retainers ($30,000 Audit; $30,000 Compliance; $20,000 Investment; $20,000 Dividend/Nominating/Closed-End) and chair retainers; ad hoc meeting fees $1,000–$2,500; special assignment quarterly fees.
    • Effective Jan 1, 2025: increases to certain committee membership and chair retainers (e.g., Audit and Compliance to $35,000; Investment membership to $30,000; Dividend/Nominating/Closed-End membership to $25,000; Board Chair to $150,000; related chair fees increased).
Item202320242025
Annual retainer (Independent Trustee)$210,000 $350,000 $350,000
Audit Committee member retainer$2,500/meeting (pre-2024) $30,000 $35,000
Compliance Committee member retainer$5,000/meeting (pre-2024) $30,000 $35,000
Investment Committee member retainer$2,500/meeting (pre-2024) $20,000 $30,000
Dividend/Nominating/Closed-End member$500–$1,250/meeting (pre-2024) $20,000 $25,000
Board Chair retainer$140,000 $140,000 $150,000
  • JLS-specific paid amounts (last fiscal year): JLS paid Medero $380; total compensation across the fund complex paid to Medero was $461,987.
  • Deferred compensation: Medero elected to defer a portion of fees; JLS-attributed deferred amount was $133 (value of assumed investment in designated Nuveen funds).

Performance Compensation

ComponentDetailsNotes
Equity (RSUs/PSUs/Options)None disclosed for Independent TrusteesCompensation is cash retainers/fees; no equity-based awards reported.
Performance metrics (TSR, revenue, ESG)None disclosedNo bonus or metric-linked pay for directors.
Clawbacks/COC/SeveranceNot applicable to Independent TrusteesFunds have no employees; officers not paid by Funds.

Other Directorships & Interlocks

CategoryEntityRoleNotes
Non-profitBaltic-American Freedom FoundationDirectorSince 2019.
Public company directorshipsNone disclosed for Medero in the proxy’s “Other Directorships” column.
Adviser/affiliate tiesNuveen/TIAA/AdviserIndependenceBoard affirms all trustees (including Medero) are independent of Adviser/TIAA.

Expertise & Qualifications

  • 30+ years in financial services spanning asset management legal leadership, government relations, and U.S. derivatives regulation (former CFTC General Counsel; former Global GC of BGI).
  • Extensive policy/industry leadership (SIFMA AMG Steering Committee Chair; MFA committee chair; long-standing roles in policy/legal organizations).
  • Legal and governance credentials; J.D. (George Washington University Law School), B.A. (St. Lawrence University).

Equity Ownership

MetricJLS (Mortgage & Income)Complex-wide context
Dollar range owned$0Proxy states each trustee’s holdings per fund and aggregate ranges for many trustees; Medero shows $0 in JLS.
Shares owned0JLS share count shown as 0 for Medero.
Ownership as % of outstanding<1%Each trustee individually owned <1% of any fund; group also <1%.
Pledged/hedged sharesNot disclosedNo pledging/hedging disclosure for trustees.
  • Ownership guideline: Board principle expects each trustee to invest at least the equivalent of one year of compensation in funds within the Nuveen fund complex (directly or via deferral). Compliance status is not enumerated per individual in the proxy.

Governance Assessment

  • Strengths

    • Independent status and no employment or board ties to Adviser/TIAA/Nuveen; sits on governance-centric committees (Compliance; Nominating & Governance; Investment), aligning with her regulatory and policy background.
    • Attendance threshold met (≥75% of meetings) amid a heavy meeting cadence at JLS (e.g., 14 Audit, 10 Dividend, 9 Special Board).
    • Significant prior regulatory and legal leadership (CFTC GC; BlackRock/Barclays policy lead) supports board risk oversight and regulatory navigation.
  • Potential concerns / investor watchpoints

    • Direct ownership in JLS is $0 and 0 shares; while the board has a complex-wide ownership expectation, lack of fund-specific holdings can be perceived as weaker alignment at the individual fund level.
    • Independent trustee compensation increased meaningfully in 2024 (to $350,000 retainer) with further committee fee increases in 2025, which, while consistent with workload expansion and consolidation, can raise governance cost sensitivity for fee-aware investors.
    • No related-party transactions or adviser-affiliation conflicts are disclosed for Medero; continue monitoring for any new interlocks.
  • Compliance and disclosure notes

    • Section 16(a) filings: Funds report compliance by trustees and officers during the last fiscal year.
    • Elections: For JLS, 2025 ballot includes Class I nominees; Medero is a continuing Class III trustee with term to 2027 (not up for JLS election in 2025).

Fixed Compensation (JLS and Complex) – Detail Table

ItemJLS amount to Medero (last FY)Deferred amount (JLS)Total compensation from fund complex to Medero (last FY)
Cash/fees$380$133$461,987
SourceJLS allocation JLS deferred fee value Total complex compensation

Performance Compensation – Metrics Table

Metric CategoryTied to Director Pay?Evidence
TSR or stock priceNoNo performance plans disclosed for trustees; retainers/fees only.
Financial/operational targetsNoNot applicable to independent trustees.
ESG/strategic goalsNoNot disclosed/applicable for trustee compensation.

Other Directorships & Interlocks – Table

TypeEntityRoleTenure
Non-profitBaltic-American Freedom FoundationDirectorSince 2019
Public companyNone disclosed

Board Governance – Committee Assignments (Current)

CommitteeRoleMembership list evidence
Compliance, Risk Management & Regulatory OversightMemberMedero listed among members.
Nominating & GovernanceMemberMedero listed among members.
InvestmentMemberMedero listed among members.
AuditNot a memberAudit membership excludes Medero.
DividendNot a memberDividend membership excludes Medero.
Closed-End FundNot a memberClosed-End membership excludes Medero.
ExecutiveNot a memberExecutive membership excludes Medero.

RED FLAGS: None material disclosed specific to Medero (no related-party transactions, no Section 16 deficiencies). Alignment watchpoint: $0 direct ownership in JLS despite complex-wide investment guideline; monitor future ownership disclosures for progress.